Most people with HPV never know they have it. The virus rarely causes symptoms, and nearly everyone who is sexually active will contract at least one strain at some point. So the short answer is: you probably can’t tell on your own. Whether you can get a definitive test depends on your sex, your age, and the type of HPV involved.
Why HPV Usually Has No Signs
HPV is a group of more than 200 related viruses, and most infections produce zero symptoms. Your immune system typically fights off the virus quietly, with roughly 70 to 80 percent of infections clearing within 12 to 19 months. Many people carry and transmit HPV without ever developing a wart, an abnormal cell, or any other clue that the virus was there. This is what makes it so common and so easy to miss.
When symptoms do appear, they show up in two broad categories: low-risk strains that cause genital warts, and high-risk strains that can eventually cause cellular changes leading to cancer. These are very different timelines. Warts typically appear 2 to 3 months after exposure, though the range can stretch from 1 to 20 months. High-risk strains work much more slowly, sometimes taking up to 10 years to progress to cancer. That long, silent window is exactly why screening matters.
Signs You Might Notice
The only visible sign of HPV that you could spot yourself is genital warts. These are usually flat, raised, or stalk-like growths that appear on or around the genitals or anus. In women, they commonly show up around the vaginal opening. In men, they tend to appear under the foreskin or on the penile shaft. They can also develop on the scrotum, perineum, or perianal skin.
Warts can be skin-colored or slightly darker, and they sometimes cluster in a cauliflower-like shape. Not every bump in the genital area is a wart. Normal skin tags, hair follicles, and other harmless growths can look similar. If you notice something new, a clinician can usually diagnose warts by visual inspection alone, though a biopsy may be needed if the lesion looks unusual (pigmented, bleeding, ulcerated, or fixed to deeper tissue).
High-risk HPV strains, the ones linked to cancer, produce no visible symptoms until the disease is advanced. HPV types 16 and 18 alone are responsible for about 76 percent of cervical cancers. These strains can also affect the throat, anus, and other areas, but they don’t announce themselves with a rash or a bump you can check for in the mirror.
Screening Options for Women
Cervical screening is the most reliable way for women to detect high-risk HPV. The two main tools are the Pap test, which looks for abnormal cervical cells, and the HPV test, which checks directly for high-risk viral DNA. Here’s how the recommended schedule breaks down by age:
- Ages 21 to 29: A Pap test every 3 years. The American Cancer Society recommends starting HPV testing at age 25 instead, but both approaches are currently in use.
- Ages 30 to 65: An HPV test every 5 years, an HPV/Pap cotest every 5 years, or a Pap test alone every 3 years. Primary HPV testing every 5 years is the preferred approach in updated guidelines.
If your Pap test comes back with a result called ASC-US, the most common abnormal finding, it means some cells look slightly off but the reason isn’t clear. Your provider will typically run an HPV test to figure out whether a high-risk strain is behind the changes. A positive HPV result may lead to closer monitoring or a procedure called a colposcopy, where the cervix is examined more closely and a small tissue sample is taken. A negative HPV result is reassuring, and you’ll likely just return for routine screening on schedule.
Your follow-up plan after any abnormal result is personalized. Providers now consider your previous screening history, any past treatments for precancerous changes, and your age before recommending next steps. An abnormal result does not mean you have cancer. It means closer monitoring is warranted.
Why There’s No Standard Test for Men
There is no FDA-approved HPV test for men. The skin on the penis is too thick to reliably collect the type of cell sample that HPV tests require, which leads to inconsistent results. Men are typically screened through visual inspection only, meaning a clinician checks for visible warts or other lesions during a physical exam.
The one exception involves anal screening. Men (and anyone) with a history of receptive anal sex may benefit from an anal Pap test, which works similarly to a cervical Pap and can detect abnormal cells in the anal canal. This isn’t routinely offered, so it’s something you’d need to specifically ask about.
For most men, HPV goes completely undetected unless warts appear. There is no blood test, urine test, or swab that can tell you whether you’re currently carrying the virus.
HPV-Related Throat and Anal Cancers
High-risk HPV can infect the throat and anus in both men and women, and these cancers are rising in prevalence. Oropharyngeal cancer linked to HPV may cause a persistent sore throat, earaches, hoarseness, swollen lymph nodes, pain when swallowing, or unexplained weight loss. Some people have no symptoms at all until the cancer is found during an exam for something else.
There is currently no approved screening test for oral HPV. Dentists and doctors may notice suspicious lesions during routine exams, but there’s no equivalent of the Pap test for the throat. This is one reason vaccination before exposure remains the most effective protection against HPV-related cancers in areas that can’t be screened.
What Clearance Looks Like
If you do test positive for HPV, it doesn’t necessarily mean you’ll face long-term health problems. The majority of infections, both high-risk and low-risk strains, are cleared by the immune system within one to two years. You won’t feel it happening. There’s no fever that breaks or symptom that resolves. The virus simply becomes undetectable.
A small percentage of high-risk infections persist, and those are the ones that can eventually cause precancerous changes. This is exactly what cervical screening is designed to catch: not the virus itself, but the cellular damage it causes over years. Catching those changes early, often a decade before they’d become cancer, is what makes screening so effective.
For people without access to cervical screening (men, and anyone with HPV in areas that aren’t routinely tested), the virus typically resolves on its own without consequence. The challenge is that there’s no way to confirm it’s gone, and no way to know if you’re one of the people where it lingers. Staying current with whatever screening is available to you, and getting vaccinated if you’re still within the recommended age range, are the most practical steps you can take.